source
- Licensing deals with Chinese biotech stay strong as big pharma pours $550M+ into cancer and obesity pipelinesWestern drug developers continue to sign licensing agreements with Chinese biotechnology firms at a steady pace, according to recent data visualizations. More than 100 such deals have been announc…
- FDA issues guidance to prevent newborn nutrition supply gapThe U.S. Food and Drug Administration announced it is taking action to address a potential supply gap of neonatal starter parenteral nutrition, which provides essential IV nutrients to premature an…